Bristol-Myers Squibb Company (BMY)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
| 12-2015 | 12-2014 | 12-2013 | 12-2012 | 12-2011 | |
| Cash Flows From Operating Activities | |||||
| Net Income | 1,631,000 | 2,029,000 | 2,580,000 | 2,501,000 | 5,260,000 |
| Depreciation Amortization | 376,000 | 467,000 | 763,000 | 973,000 | 628,000 |
| Income taxes - deferred | -347,000 | -542,000 | -491,000 | -1,230,000 | 415,000 |
| Accounts receivable | -942,000 | -252,000 | -504,000 | 648,000 | -220,000 |
| Accounts payable and accrued liabilities | N/A | N/A | N/A | N/A | 593,000 |
| Other Working Capital | -735,000 | 242,000 | 194,000 | -631,000 | 104,000 |
| Other Operating Activity | 2,122,000 | 1,204,000 | 1,003,000 | 4,680,000 | -1,940,000 |
| Operating Cash Flow | $2,105,000 | $3,148,000 | $3,545,000 | $6,941,000 | $4,840,000 |
| Cash Flows From Investing Activities | |||||
| Change In Deposits | -349,000 | -1,624,000 | -44,000 | -3,607,000 | -859,000 |
| PPE Investments | -820,000 | -526,000 | -537,000 | -548,000 | -367,000 |
| Net Acquisitions | -403,000 | 3,366,000 | 9,000 | -7,462,000 | -211,000 |
| Sale Of Investment | N/A | N/A | N/A | 4,890,000 | N/A |
| Investing Cash Flow | $-1,572,000 | $1,216,000 | $-572,000 | $-6,727,000 | $-1,437,000 |
| Cash Flows From Financing Activities | |||||
| Change In Short Term Borrowing | -449,000 | 244,000 | 198,000 | 49,000 | -1,000 |
| Debt Issued | 1,268,000 | 0 | 892,000 | 1,950,000 | N/A |
| Debt Repayment | -1,957,000 | -676,000 | N/A | -2,108,000 | -78,000 |
| Common Stock Issued | N/A | 288,000 | 564,000 | 463,000 | 601,000 |
| Common Stock Repurchased | 0 | 0 | -433,000 | -2,403,000 | -1,221,000 |
| Dividend Paid | -2,477,000 | -2,398,000 | -2,309,000 | -2,286,000 | -2,254,000 |
| Other Financing Activity | -9,000 | 105,000 | 20,000 | 2,000 | 296,000 |
| Financing Cash Flow | $-3,624,000 | $-2,437,000 | $-1,068,000 | $-4,333,000 | $-2,657,000 |
| Exchange Rate Effect | -95,000 | 58,000 | 25,000 | -1,000 | -3,000 |
| Beginning Cash Position | 5,571,000 | 3,586,000 | 1,656,000 | 5,776,000 | 5,033,000 |
| End Cash Position | 2,385,000 | 5,571,000 | 3,586,000 | 1,656,000 | 5,776,000 |
| Net Cash Flow | $-3,186,000 | $1,985,000 | $1,930,000 | $-4,120,000 | $743,000 |
| Free Cash Flow | |||||
| Operating Cash Flow | 2,105,000 | 3,148,000 | 3,545,000 | 6,941,000 | 4,840,000 |
| Capital Expenditure | -820,000 | -526,000 | -537,000 | -548,000 | -367,000 |
| Free Cash Flow | 1,285,000 | 2,622,000 | 3,008,000 | 6,393,000 | 4,473,000 |